Benzinga | Dec 22, 2021 05:36AM EST

Jefferies Downgrades ALX Oncology Holdings to Hold, Lowers Price Target to $25

Jefferies downgrades ALX Oncology Holdings (NASDAQ:ALXO) from Buy to Hold and lowers the price target from $65 to $25.